Comparative genomics of two Asian medicinal leeches Hirudo nipponia and Hirudo tianjinensis
Basic science / genomics published in Int J Biol Macromol (2024)
Abstract
Leeches secrete various biologically active substances which have important medical and pharmaceutical values in antithrombotic treatments. Here, we provide a high quality genome of two Asian medicinal leeches Hirudo nipponia and Hirudo tianjinensis, based on which, we identified 22 antithrombotic gene families, including fourteen coagulation inhibitors, four platelet aggregation inhibitors, three fibrinolysis enhancers, and one tissue penetration enhancer. The total numbers of antithrombotic genes were similar between H. nipponia (N = 86) and H. tianjinensis (N = 83). Molecular evolution analysis showed that no significant differences were detected between the two species in any of the three selection indices (dN, dS, and dN/dS), nor in the number of sites under positive/purifying selection. RNA-Seq based gene expression analysis showed that the overall expression patterns of the antithrombotic gene families were not significantly deviated between the two species. Our results indicated that there were rather close similarities between the two leeches on genomic characteristics, especially for the molecular evolution and expression of antithrombotic genes. Our study provides the most comprehensive collection of antithrombotic biomacromolecules from the two Asian medicinal leeches to date. These results will greatly facilitate the research and application of leech derivatives for medical and pharmaceutical purposes of thrombosis.
Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.
Resumen
Comparative genomic analysis of Hirudo nipponia and Hirudo tianjinensis Asian medicinal leeches characterizing bioactive-compound diversity.
Por qué esto importa para la hirudoterapia
Este estudio de genómica comparativa proporciona un mapa genómico de alta calidad de dos sanguijuelas medicinales asiáticas, Hirudo nipponia e Hirudo tianjinensis, para identificar biomacromoléculas antitrombóticas. Los investigadores identificaron 22 familias génicas antitrombóticas —incluidos inhibidores de la coagulación, inhibidores de la agregación plaquetaria y potenciadores de la fibrinólisis— con recuentos génicos y patrones de expresión similares en ambas especies. Esta investigación es fundamentalmente importante para el ámbito de la ASH porque mapea de forma exhaustiva la base genética del secretoma de la sanguijuela, identificando los compuestos específicos responsables de las propiedades antitrombóticas utilizadas en la hirudoterapia moderna. Como análisis genómico y transcriptómico, el estudio representa ciencia básica preclínica más que un ensayo clínico, proporcionando los datos biológicos fundamentales necesarios para futuras aplicaciones terapéuticas.
Citación
Comparative genomics of two Asian medicinal leeches Hirudo nipponia and Hirudo tianjinensis.
Zhao et al. · International journal of biological macromolecules, 2024
Contexto clínico relacionado
Explore cómo esta investigación se conecta con la práctica clínica
Añadido a la biblioteca ASH: May 27, 2026 · Última actualización del sitio: 18 de junio de 2026